logo

For the Inventor, By the Inventor

Highland Park, NJ, United States of America

Ramesh C Pandey

This inventor holds 9 USPTO granted patents, plus 2 CIPO patents. Top assignee: Xechem International, Inc.. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh C Pandey. Retrieved from https://idiyas.com/inventor/ramesh-c-pandey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 88.9


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 240(Granted Patents)


Company Filing History:

goldMedal9 out of 10 
 
Xechem International, Inc.
 patents

Years Active: 1997-2004

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 6765015 - Halogenated paclitaxel derivatives (2004-07-20),
2. 6177456 - Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor (2001-01-23),
3. D411308 - Covered multi-well assay plate (1999-06-22),
4. 5854278 - Preparation of chlorinated paclitaxel analogues and use thereof as (1998-12-29),
5. 5840930 - Method for production of 2', 3' dihalocephalomannine (1998-11-24),
6. 5840748 - Dihalocephalomannine and methods of use therefor (1998-11-24),
7. 5817510 - Device and method for evaluating microorganisms (1998-10-06),
8. 5807888 - Preparation of brominated paclitaxel analogues and their use as (1998-09-15),
9. 5654448 - Isolation and purification of paclitaxel from organic matter containing (1997-08-05),

Title: Ramesh C Pandey: Innovator in Anti-Cancer Research

Introduction

Ramesh C Pandey is a notable inventor based in Highland Park, NJ (US), recognized for his contributions to the field of anti-cancer research. With a total of nine patents to his name, he has made significant strides in developing novel therapeutic agents.

Latest Patents

Among his latest inventions are halogenated paclitaxel derivatives, which are directed towards novel compounds that serve as effective anti-tumor agents. Additionally, he has developed monohalocephalomannines that exhibit anticancer and antileukemic activity, along with methods for their preparation.

Career Highlights

Ramesh has worked with several companies throughout his career, including Xechem International, Inc. and his own venture, Ramesh C. Pandey. His work has been pivotal in advancing cancer treatment options.

Collaborations

He has collaborated with notable individuals in the field, including Luben K Yankov and Swami Nathan, contributing to a rich exchange of ideas and innovations.

Conclusion

Ramesh C Pandey's work in the development of anti-cancer agents showcases his dedication to improving healthcare through innovation. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…